For those who think the Free Trade Agreement will do no harm to the Pharmaceutical Benefits Scheme, it’s worth reading this NYT piece, which focuses on impacts in the US>.
By the way, although we may pay more for medicine, we are the way to a cure for the dread affliction of linkrot. The NYT has provided weblog-safe links using its RSS feed. Thanks to Jack Strocchi for alerting me to this.
John Quiggin 
A Bohemian pundit alerted me to the alarming fact that Australia parades itself in alarming blue on Zuckerman graph!
Ethan Zuckerman is carrying out research into the relationship between media attention given to a country and economic and developmental factors. He visualizes this relationship by producing maps that indicate degree of attention (red is high attention, blue is low)
PS:
White House Staff Salary Analysis: Leaked list of what folks working in the Bush Administrayshun make: No Surprises here
Blogosphere: ((Wages: Brayden King, Stephen Landsburg, Brad Delong, Robert Waldmann, Tyler Cowen, and John Quiggin)) Business Week: (((Series of articles comparing pensions around the world)))
No need to be alarmed, the graph for Australia has changed from blue to zone red!
pharmaceutical benefits – the truth is coming out
John Quiggin points to a NYT piece which explores the FTA and the Pharmaceutical Benefits Scheme from the US perspective. The comments on his post will track the responses. For my part, I am going to post the whole thing,…
pharmaceutical benefits – the truth is coming out
John Quiggin points to a NYT piece which explores the FTA and the Pharmaceutical Benefits Scheme from the US perspective. The comments on his post will track the responses. For my part, I am going to post the whole thing,…
Start Paddling
A special nod of acknowledgement to John Quiggan and David Tiley for publicising the issue of the impending demise of…